Proton magnetic resonance spectroscopy of the thalamus in chronic complex regional pain syndrome (CRPS) type-1 patients

Pain Clinic

Volumn 14, Issue 4, 2002, Pages 347-351

  Fukui, S ^a   Nosaka, S ^a  

^a SHIGA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

Author keywords

Complex regional pain syndrome (CRPS) type I; Proton magnetic resonance spectroscopy (1H MRS); Thalamus

Indexed keywords

N ACETYLASPARTIC ACID;

ADULT; ARTICLE; BRAIN BLOOD FLOW; BRAIN ISCHEMIA; CHEMICAL ANALYSIS; CHRONIC DISEASE; CLINICAL ARTICLE; COMPLEX REGIONAL PAIN SYNDROME; DIAGNOSTIC IMAGING; HUMAN; NERVE CONDUCTION; NEUROPATHIC PAIN; PATHOGENESIS; PROTON NUCLEAR MAGNETIC RESONANCE; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; THALAMUS;

EID: 0036980992     PISSN: 01691112     EISSN: None     Source Type: Journal    
DOI: 10.1163/15685690260494915     Document Type: Article

References (15)

1. Treede RD, Daniel R, Kenshalo DR, Richard H, Gracely RH, Jones AKP, The cortical representation of pain, Pain 79, 105-11 (1999).
2. Hsieh JC, Belfrage M, Stone-Elander S, Hansson P, Ingvar M, Central representation of chronic ongoing neuropathic pain studied by positron emission tomography, Pain 63, 225-36 (1995).
3. Iadarola MJ, Max MB, Berman KF, Byas-Smith MG, Coghill RC, Gracely RH, Bennett GJ, Unilateral decrease in thalamic activity observed with positron emission tomography in patients with chronic neuropathic pain, Pain 63, 55-64 (1995).
4. Fukumoto M, Uchida T, Zinchuk VS, Yamamoto H, Yshida S, Contralateral thalamic perfusion in patients with reflex dystrophy syndrome, The Lancet 354, 1790-1 (1999).
5. Tsuchida C, Kimura H, Sadato N, Tsuchida T, Tokuriki Y, Yonekura Y, Evaluation of brain metablism in steno-occlusive carotid artery didease by proton MR spectroscopy: A correlative study with oxygen metablism by PET, J Nuc Med 41, 1357-62 (2000).
6. Jessen F, Block W, Träber F, Keller E, Flacke S, Papassotripoulos A, Lamerichs R, Heum R, Schild HH, Proton MR spectroscopy detects a relative decrease of N-acetylaspartate in the medial temporal lobe of patients with AD, Neurology 55, 684-8 (2000).
7. Shiino A, Matsuda M, Morikawa S, Inubushi T, Akiguchi I, Handa J, Proton magnetic resonance spectroscopy with dementia, Surg Neurol 39, 143-7 (1993).
8. Omori M, Murata T, Kimura H, Koshimoto Y, Kado H, Ishimori Y, Ito H, Wada Y, Thalamic abnormalities in patients with schizophrenia revealed by proton magnetic resonance spectroscopy, Psychiatry Res 98, 155-62 (2000).
9. Apkarian AV, Thomas PS, Krauss BR, Szeverenyi NM, Prefrontal cortical hyperactivity in patients with sympathetically mediated chronic pain, Neurosci Lett 311, 193-7 (2001).
10. Hamakawa H, Kato T, Murashita J, Kato N, Quantitive proton magnetic resonance spectroscopy of the basal ganglia in patients with affected disorders, EurArch Psychiatry Clin Neurosci 248, 53-8 (1998).
11. Bruhn H, Frahm J, Gyngell ML, Merboldt KD, Hanicke W, Sauter R, Cerebral metabolism in man after acute stroke: new observations using localized proton NMR spectroscopy, Mag Reson Med 9, 126-31 (1989).
12. Gideon P, Sperling B, Arlien-Scborg P, Olsen TS, Heniksen O, Long-term follow-up of cerebral infarction patients with proton magnetic resonance spectroscopy, Stroke 25, 967-73 (1994).
13. Shonk TK, Moats RA, Gifford P, Michaelis T, Mandigo JC, Izumi J, Ross BD, Probable Alzheimer disease: Diagnosis with proton MR spectroscopy, Radiology 195, 65-72 (1995).
14. Menon DK, Sargentoni J, Peden CJ, Bell JD, Cox IJ, Countts GA, Baudouin C, Newman CG, Proton MR spectroscopy in herpes simplex encephalitis: assessment of neural loss, J Computer Assited Tomography 14, 449-52 (1990).
15. 1H MR spectroscopy, Neuroradiology 215, 807-17 (2000).